FIELD: organic chemistry, pharmaceutical chemistry, medicine. SUBSTANCE: invention relates to medicinal agent used for treatment of MCP-1-mediated diseases in warm-blooded animals involving compound of the formula (I) 
. EFFECT: enhanced effectiveness of treatment, valuable medicinal properties. 12 cl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1996 |
|
RU2198878C2 |
| AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1996 |
|
RU2182574C2 |
| DERIVATIVES OF 4-MERCAPTOPYRROLIDINE AS INHIBITORS OF FARNESYLTRANSFERASE | 1996 |
|
RU2191773C2 |
| DERIVATIVES OF QUINAZOLINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF, METHOD OF ATTAINMENT OF ANTIANGIOGENIC EFFECT AND/OR EFFECT OF BLOOD VESSEL PERMEABILITY REDUCTION IN WARM-BLOODED ANIMAL | 1997 |
|
RU2198879C2 |
| ANTIBACTERIAL PIPERIDINE DERIVATIVES | 2006 |
|
RU2424240C2 |
| DERIVATIVES OF QUINAZOLINE AS INHIBITORS OF ANGIOGENESIS | 2000 |
|
RU2262935C2 |
| QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF VESSEL ENDOTHELIUM GROWTH FACTOR | 1997 |
|
RU2196137C2 |
| DERIVATIVES OF QUINAZOLINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND METHOD OF ACHIEVEMENT OF ANTI-ANGIOGENIC EFFECT AND/OR EFFECT OF DECREASE OF VASCULAR PENETRATION WITH THEIR USING | 1996 |
|
RU2194701C2 |
| DERIVATIVES OF QUINAZOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON SAID | 1993 |
|
RU2127263C1 |
| DERIVATIVES OF THIOPHEN AND PHARMACEUTICAL COMPOSIITON (VERSIONS) | 2003 |
|
RU2359967C2 |
